A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Treatment Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering products of uncertain source.
Several experts said the demand for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, risking fines, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the platform has removed problematic content and prohibited related keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Online Trading Operations
Research also discovered groups with up to 9,000 participants marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, positive testimonials and detailed instructions for preparing or administering at home.
Within minutes of entering one community, a vendor shared contact information, where most purchases take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Product Information and Pricing
Within these groups, posts display dark colored packages with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to potentially significant medical dangers”.
